WEST PHARMACEUTICAL SERVICES, INC. Severance Costs (Deprecated 2013-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Severance Costs (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SeveranceCosts · last filed 2013-08-05
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2013-06-30 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $100.00K, a 87.50% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$1.10M.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for the quarter ending 2012-06-30 was -$200.00K, a 166.67% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for fiscal 2012 was -$1.20M, a 152.17% decline from fiscal 2011.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for fiscal 2011 was $2.30M, a 78.10% decline from fiscal 2010.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for fiscal 2010 was $10.50M, a 250.00% increase from fiscal 2009.
- WEST PHARMACEUTICAL SERVICES, INC. severance costs (deprecated 2013-01-31) for fiscal 2009 was $3.00M.
| Period end | Severance Costs (Deprecated 2013-01-31) 3 month | Severance Costs (Deprecated 2013-01-31) 6 month | Severance Costs (Deprecated 2013-01-31) 9 month | Severance Costs (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-06-30 | $0.00 10-Q · filed 2013-08-05 | $0.00 10-Q · filed 2013-08-05 | ||
| 2012-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$1.00M derived: sum of 2 quarters · filed 2013-02-27 | -$1.20M derived: sum of 3 quarters · filed 2013-08-05 | -$1.20M 10-K · filed 2013-02-27 |
| 2012-09-30 | -$1.10M 10-Q · filed 2012-11-05 | -$1.30M derived: sum of 2 quarters · filed 2013-08-05 | -$1.30M 10-Q · filed 2012-11-05 | -$500.00K derived: sum of 4 quarters · filed 2013-08-05 |
| 2012-06-30 | -$200.00K 10-Q · filed 2013-08-05 | -$200.00K 10-Q · filed 2013-08-05 | $600.00K derived: sum of 3 quarters · filed 2013-08-05 | $300.00K derived: sum of 4 quarters · filed 2013-08-05 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-04 | $800.00K derived: sum of 2 quarters · filed 2013-02-27 | $500.00K derived: sum of 3 quarters · filed 2013-02-27 | $800.00K derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $500.00K derived: sum of 2 quarters · filed 2013-02-27 | $800.00K derived: sum of 3 quarters · filed 2013-02-27 | $2.30M 10-K · filed 2013-02-27 |
| 2011-09-30 | -$300.00K 10-Q · filed 2012-11-05 | $0.00 derived: sum of 2 quarters · filed 2012-11-05 | $1.50M 10-Q · filed 2012-11-05 | $11.60M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $300.00K 10-Q · filed 2012-08-06 | $1.70M 10-Q · filed 2012-08-06 | $11.90M derived: sum of 3 quarters · filed 2013-02-27 | $12.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $1.50M 10-Q · filed 2012-05-04 | $11.60M derived: sum of 2 quarters · filed 2013-02-27 | $11.70M derived: sum of 3 quarters · filed 2013-02-27 | $11.70M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $10.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $10.20M derived: sum of 2 quarters · filed 2013-02-27 | $10.20M derived: sum of 3 quarters · filed 2013-02-27 | $10.50M 10-K · filed 2013-02-27 |
| 2010-09-30 | $100.00K 10-Q · filed 2011-11-07 | $100.00K derived: sum of 2 quarters · filed 2011-11-07 | $400.00K 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $0.00 10-Q/A · filed 2011-08-08 | $400.00K 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $3.00M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |